

	For the Three Months Ended		For the Six Months Ended		For the Three Months Ended		For the Six Months Ended
	June 30, 2017	June 30, 2016	June 30, 2017	June 30, 2016	June 30, 2018	June 30, 2017	June 30, 2018	June 30, 2017

REVENUE
Total Revenue	955,423	1,010,981	1,950,851	2,069,557	642,480	955,423	1,414,738	1,950,851

COST OF SERVICES
Total Cost of Services	697,887	769,757	1,399,372	1,537,047	497,257	697,887	1,038,716	1,399,372

Gross Profit	257,536	241,224	551,479	532,510	145,223	257,536	376,022	551,479
OPERATING EXPENSES
Selling expenses	14,582	16,364	31,666	32,661	4,717	14,582	15,260	31,666
General and administrative	89,635	101,196	215,564	200,807	119,085	89,635	229,001	215,564
Salaries, wages and related expenses	177,895	175,812	347,736	347,095	151,432	177,895	311,237	347,736
Professional and consulting fees	20,684	29,617	67,983	79,860	23,347	20,684	66,105	67,983
Total Operating Expenses	302,796	322,989	662,949	660,423	298,581	302,796	621,603	662,949
LOSS FROM OPERATIONS	(45,260)	(81,765)	(111,470)	(127,913)	(153,358)	(45,260)	(245,581)	(111,470)

OTHER INCOME (EXPENSE):
Interest income	127	107	208	202	38	127	119	208
Gain/(loss) on derivative	24,392	57,732	45,059	145,979	-	24,392	-	45,059
Interest expense	(25,518)	(25,250)	(50,993)	(50,500)	(25,820)	(25,518)	(51,481)	(50,993)
Other income (expense)	-	-	-	-	-	-	-	-
Total Other Income (Expense)	(999)	32,589	(5,726)	95,681
INCOME (LOSS) BEFORE INCOME TAXES	(46,259)	(49,176)	(117,196)	(32,232)
Total Other Expense					(25,782)	(999)	(51,362)	(5,726)
LOSS BEFORE INCOME TAXES					(179,140)	(46,259)	(296,943)	(117,196)
CURRENT INCOME TAX EXPENSE (BENEFIT)	-	-	-	-	-	-	-	-
DEFERRED INCOME TAX EXPENSE (BENEFIT)	-	-	-	-	-	-	-	-
NET INCOME (LOSS) AVAILABLE TO COMMON SHAREHOLDERS	(46,259)	(49,176)	(117,196)	(32,232)
NET LOSS					(179,140)	(46,259)	(296,943)	(117,196)


BASIC INCOME PER COMMON SHARE	(0.004)	(0.004)	(0.01)	(0.003)
BASIC LOSS PER COMMON SHARE					(0.02)	(0.004)	(0.03)	(0.01)
BASIC WEIGHTED AVERAGE COMMON SHARES OUTSTANDING	11,265,631	11,265,631	11,265,631	11,265,631	11,265,631	11,265,631	11,265,631	11,265,631
DILUTED INCOME PER COMMON SHARE -	(0.004)	(0.004)	(0.01)	(0.003)
DILUTED LOSS PER COMMON SHARE -					(0.02)	(0.004)	(0.03)	(0.01)
DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING	11,265,631	11,265,631	11,265,631	11,265,631	11,265,631	11,265,631	11,265,631	11,265,631

The accompanying notes are an integral part of these consolidated financial statements.

FUTURE HEALTHCARE OF AMERICA

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


		Six Months Ended				Six Months Ended
		June 30,				June 30,
		2017		2016		2018		2017

Cash Flows from Operating Activities
Net income	$	(117,197)	$	(32,232)
Adjustments to reconcile net income to net cash used by operating activities:
Interest to be paid with stock		50,500		50,500
Depreciation and amortization expense		-		33
Net loss					$	(296,943)	$	(117,197)
Adjustments to reconcile net loss to net cash used by operating activities:
Allowance for doubtful accounts						25,000		-
Gain on derivative instruments		(45,059)		(145,979)		-		(45,059)
Change in assets and liabilities:
Accounts receivable		(84,464)		139,157		(131,015)		(84,464)
Prepaid expenses		2,851		(4,774)		41,456		25,067
Accounts payable		29,172		21,927		147,384		29,172
Accrued expense		46,701		(22,491)		93,460		97,201
Deferred revenue		(6,838)		20,591		17,661		(6,838)
Net Cash Provided/(Used) by Operating Activities		(124,334)		26,732		(102,997)		(102,118)

Cash Flows from Investing Activities:		-		-		-		-
Net Cash Provided/ (Used) by Investing Activities		-		-		-		-

Cash Flows from Financing Activities:
Proceed from insurance financing		22,216		-
Proceed from related party advance						23,000		-
Re-payment of insurance financing		(8,754)		-		(23,537)		(8,754)
Net Cash Provided/ (Used) by Financing Activities		13,462		-		(537)		(8,754)

Net Increase (Decrease) in Cash		(110,872)		26,732		(103,534)		(110,872)
Cash at Beginning of Period		206,352		481,115		158,072		206,352
Cash at End of Period	$	95,480	$	507,847	$	54,538	$	95,480

Supplemental Disclosures of Cash Flow Information
Cash paid during the periods for:
Interest		-		-		982		493
Income taxes		-		-		-		-

Supplemental Disclosures of Non-Cash Investing and Financing

Activities:


	For the Six Months Ended
	June 30,
NON-CASH EXPENDITURES	2018	2017
Prepaid insurance premiums financed	49,151	22,216

For the Six Months Ended

June 30,
NON-CASH EXPENDITURES

2017

2016
Depreciation expense

-

33
Interest expense to be paid with stock

50,500

50,500
Change in FMV of derivative liability

(45,059)

(145,979)
Total non-cash expenditures

5,441

(95,446)

The accompanying notes are an integral part of these consolidated financial statements.

FUTURE HEALTHCARE OF AMERICA

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization – On June 22, 2012, FAB Universal (FAB) formed Future Healthcare of America (“FHA”), a wholly owned subsidiary. On October 1, 2012, FHA operations were spun-off in a 1 for 1 dividend to the shareholders of record of FAB on September 5, 2012, the record date. On November 14, 2014, FHA organized Future Healthcare Services Corp. (“FHS”), and transferred all the shares of Interim to FHS. Interim Healthcare of Wyoming, Inc. (“Interim”), a Wyoming corporation, a wholly owned subsidiary of FHS, was organized on September 30, 1991. Interim operates primarily in the home healthcare and healthcare staffing services in Wyoming and Montana. On April 3, 2007, Interim purchased the operations of Professional Personnel, Inc., d.b.a., Professional Nursing Personnel Pool.

Consolidation - The financial statements presented reflect the accounts of FHA, FHS and Interim. All inter-company transactions have been eliminated in consolidation.

Accounting Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Management made assumptions and estimates for determining reserve for accounts receivable, obsolete inventory and in determining the impairment of definite life intangible assets and goodwill. Actual results could differ from those estimated by management.

Cash and Cash Equivalents – The Company considers all highly liquid investments with an original maturity date of three months or less when purchased to be cash equivalents. At June 30, ~~2017,~~2018, the Company had no cash balances in excess of federally insured limits.

Accounts Receivable - Accounts receivable consist of trade receivables arising in the normal course of business. At June 30, ~~2017 and 2016,~~2018, the Company has an allowance for doubtful accounts of ~~$20,200,~~$45,200, which reflects the Company's best estimate of probable losses inherent in the accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available evidence. During the six months ended June 30, ~~2017~~2018 and ~~2016,~~2017, the Company ~~adjusted the allowance for~~recorded bad debt ~~by $0.~~expense of $25,000 and $0, respectively.

Depreciation - Depreciation of property and equipment is provided on the straight-line method over the estimated useful lives.

Income /(Loss) Per Share - The Company computes income (loss) per share in accordance with Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260 Earnings Per Share, which requires the Company to present basic earnings per share and diluted earnings per share when the effect is dilutive (see Note 7).

Leases - The Company accounts for leases in accordance with Financial FASB ASC Topic 840, (formerly Statement of Financial Accounting Standards SFAS No. 13 "Accounting for Leases"). Leases that meet one or more of the capital lease criteria of standard are recorded as a capital lease, all other leases are operating leases.

Income Taxes - The Company accounts for income taxes in accordance with FASB ASC Topic 740 Accounting for Income Taxes. This topic requires an asset and liability approach for accounting for income taxes (see Note 8).

Advertising Costs - Advertising costs are expensed as incurred and amounted to ~~$19,456~~$14,836 and ~~$20,281~~$19,456 for the periods ending June 30, ~~2017~~2018 and ~~2016,~~2017, respectively.

FUTURE HEALTHCARE OF AMERICA

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Fair Value of Financial Instruments – The Company accounts for fair value measurements for financial assets and financial liabilities in accordance with FASB ASC Topic 820. The authoritative guidance, which, among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the exit price, representing the amount that would either be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

•

Level 1. Observable inputs such as quoted prices in active markets for identical assets or liabilities;

•

Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

•

Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

Unless otherwise disclosed, the fair value of the Company’s financial instruments including cash, accounts receivable, prepaid expenses, and accounts payable and accrued expenses approximates their recorded values due to their short-term maturities.

Revenue Recognition - ~~Revenue is generated~~On January 1, 2018, the Company adopted Accounting Standards Codification Topic 606, “Revenue from ~~various payer’s including Medicare, Medicaid, Insurance Companies,~~Contracts with Customers,” which includes clarifying ASUs issued in 2015, 2016 and ~~various other entities and individuals. In accordance with FASB ASC Topic 605,~~ 2017 (“new revenue standard”). The new revenue standard did not have a material impact on revenue recognition. The Company does not expect the impact of the adoption of the new standard to be material to net income on an ongoing basis.

Revenue is recognized when ~~persuasive evidence~~performance obligations with the customer are satisfied which occurs when services are provided to the customer. Revenue is measured as the amount of ~~an arrangement exists,~~consideration expected to be received in exchange for providing services. The Company's sales contain performance obligations satisfied at a point in time when the services ~~have been provided,~~are provided.

Generally, the ~~price of services~~time between when revenue is ~~fixed or determinable,~~recognized and ~~collection~~when payment is ~~reasonably assured. Payments~~due is not significant. Pre-payments received prior to ~~services being provided~~satisfaction of performance obligations through the Recovery Audit Program or RAP payments from Medicare are recorded as a ~~liability (deferred revenue) until such services are performed. Revenue is recorded as net~~deferred revenue ~~where contractual adjustments~~liability. Given the insignificant days between revenue recognition and ~~discounts are deducted from Gross Revenue to determine net revenue.~~receipt of payment, financing components do not exist between the Company and its customers.

~~Derivative Financial Instruments~~ – The Company is required to recognize all of its derivative instruments as either assets or liabilities in the Consolidated Balance Sheets at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated, and is effective, as a hedge and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, or cash flow hedge. Gains and losses related to a hedge are either recognized in income immediately to offset the gain or loss on the hedged item or are deferred and reported as a component of Accumulated Other Comprehensive Income in the Stockholders' Equity and subsequently recognized in Net income when the hedged item affects Net income. The change in fair value of the ineffective portion of a financial instrument is recognized in Net income immediately. The gain or loss related to financial instruments that are not designated as hedges are recognized immediately in Net income.following table disaggregates revenue by category:


		For the six months ended June 30, 2018
	Medicare		Private Pay		Medicaid		Staffing		Ins.		Total
Wyoming	$	319,107	$	210,026	$	91,410	$	-	$	18,977	$	639,520
Montana	-		144,822		91,654		485,305		53,437		775,218
Total Revenues	$	319,107	$	354,848	$	183,064	$	485,305	$	72,414	$	1,414,738

~~Recently Enacted Accounting Standards -~~ In May 2014, the Financial Accounting Standards Board (FASB) issued a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. On July 9, 2015, the FASB agreed to delay the effective date by one year; accordingly, the new standard is effective for us beginning in the first quarter of 2018 and we expect to adopt it at that time. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We have not yet selected a transition method, nor have we determined the impact of the new standard on our consolidated financial statements.

FUTURE HEALTHCARE OF AMERICA

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued


		For the three months ended June 30, 2018
	Medicare		Private Pay		Medicaid		Staffing		Ins.		Total
Wyoming	$	135,235	$	93,749	$	45,210	$	-	$	4,680	$	278,874
Montana	-		76,008		50,825		209,898		26,875		363,606
Total Revenues	$	135,235	$	169,757	$	96,035	$	209,898	$	31,555	$	642,480

Derivative Financial Instruments – In July 2017, the FASB issued ASU No. 2017-11, (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. The new standard applies to issuers of financial instruments with down-round features. A down-round provision is a term in an equity-linked financial instrument (i.e. a freestanding warrant contract or an equity conversion feature embedded within a host debt or equity contract) that triggers a downward adjustment to the instrument’s strike price (or conversion price) if equity shares are issued at a lower price (or equity-linked financial instruments are issued at a lower strike price) than the instrument’s then-current strike price. The purpose of the feature is typically to protect the instrument’s counterparty from future issuances of equity shares at a more favorable price. The ASU amends (1) the classification of such instruments as liabilities or equity by revising the certain guidance relative to evaluating if they must be accounted for as derivative instruments and (2) the guidance on recognition and measurement of freestanding equity-classified instruments. For the Company, this ASU is effective January 1, 2019, with early adoption permitted.

During the period ending June 30, 2018, we adopted the requirements of the new guidance as of January 1, 2018, utilizing the modified retrospective method of transition. As a result, we recorded a cumulative adjustment to retained earnings as of January 1, 2018, to reflect the effect of the new guidance.

The impact of adopting the new guidance resulted in a decrease in the previously recorded derivative liability, an increase in additional paid-in capital and a reduction of retained earnings related to the down-round provisions in the Convertible Note Payable and warrants (see Note 4).

The modified retrospective method of transition requires us to disclose the effect of applying the new guidance on each item included in our 2018 financial statements.

Following are the line items from our balance sheet as of June 30, 2018, that were affected, the amounts that would have been reported under the former guidance, the effects of applying the new guidance, and the balances reported under the new guidance:


	Amounts that	Effects of	Balance
	would have	applying	As
	been reported	new guidance	reported
Assets:	-	-	-
Liabilities
Derivative liability	(21,632)	21,632	-
Stockholders' Deficit
Accumulated Deficit	2,727,626	875,628	3,603,254
Additional Paid-In Capital	(1,313,160)	(897,260)	(2,210,420)

FUTURE HEALTHCARE OF AMERICA

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

The following are the line items from the statement of operations for the six-month period ending June 30, 2018, that were affected, the amounts that would have been reported under the former guidance, the effects of applying the new guidance, and the amounts reported under the new guidance:


Statement of operations	Amounts that would have been reported	Effects of applying new guidance	Balance As Reported
Interest expense	29,387	22,094	51,481
Net income	(274,849)	(22,094)	(296,943)

The following are the line items from the statement of operations for the three-month period ending June 30, 2018, that were affected, the amounts that would have been reported under the former guidance, the effects of applying the new guidance, and the amounts reported under the new guidance:


Statement of operations	Amounts that would have been reported	Effects of applying new guidance	Balance As Reported
Interest expense	9,884	15,936	25,820
Net income	(163,204)	(15,936)	(179,140)

Recently Enacted Accounting Standards -In February 2016, the FASB issued changes to the accounting for leases that primarily affect presentation and disclosure requirements. The new standard will require the recognition of a right to use asset and underlying lease liability for operating leases with an initial life in excess of one year. This standard is effective for us beginning in the first quarter of 2019. We have not yet determined the impact of the new standard on our consolidated financial statements.

Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

NOTE 2 - GOING CONCERN

The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles of the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has incurred losses, an accumulated deficit and has a short-term note payable in excess of anticipated cash. These factors raise substantial doubt about the ability of the Company to continue as a going ~~concern.~~concern for a period of one year from the issuance of these financial statements. There is no assurance that the Company will be successful in achieving profitable operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

NOTE 3 - PROPERTY & EQUIPMENT

The following is a summary of property and equipment at:

Life

June 31,
2017

December 31,
2016

Furniture, fixtures and equipment
2-10 yrs
$
36,384
$
36,384

36,384

36,384

Less: Accumulated depreciation

(36,384)

(36,384)

Property & equipment, net

$
-
$
-

Life

June 30,
2018

December 31,
2017

Furniture, fixtures, and equipment
2-10 yrs
$
36,384
$
36,384

36,384

36,384

Less: Accumulated depreciation

(36,384)

(36,384)

Property & equipment, net

$
-
$
-

Depreciation expense for the periods ended June 30, ~~2017~~2018 and ~~2016~~2017 was $0 and ~~$33,~~$0, respectively.

FUTURE HEALTHCARE OF AMERICA

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 4 – ~~VARIABLE RATE SENIOR SECURED~~NOTES PAYABLE AND CONVERTIBLE DEBENTURE

On September 9, 2013, the Company closed a Subscription Agreement by which one institutional investor purchased a) a Variable Rate Senior Secured Convertible Note payable having a total principal amount of $1,010,000, convertible into common shares of the Company at $0.25 per share and maturing March 9, 2015; b) Warrants to purchase a total of 3,030,000 shares of common stock, at $0.50 per share, exercisable for four years, and c) a greenshoe to purchase a total of 2,000,000 shares of common stock at $0.25 per share, exercisable for one year from the closing date. The note and warrants have a down-round provision, wherein if the Company issues common stock or equity-based instruments with lower prices or sticke prices, the note and warrants exercise prices will be adjusted to match the lower prices. On September 9, 2014 the greenshoe expired unexercised. On March 9, 2015, the Note matured.

As the note has not been paid nor extended, the outstanding principal, plus accrued but unpaid interest, liquidated damages and other amounts, became due and payable at the election of the holder. The holder has not made such an election. Effective December 14, 2017, the note payable was amended to reduce the conversion price from $0.25 per share to $0.10 per share.

The fair value of the beneficial conversion feature of the warrants and greenshoe totaled $952,254 and was recorded as a derivative liability. The Company recorded a discount on the note for beneficial conversion feature of the note. The $952,254 discount on the beneficial conversion feature was amortized as interest expense over the term of the note. As of June 30, 2017, the Company has amortized $952,254 of the discount, with no remaining unamortized discount being offset against the outstanding balance of the note in the accompanying balance sheet. As of June 30, 2017,2018, the Company had accrued interest payable on the debenture of ~~$284,302.~~

~~FUTURE HEALTHCARE OF AMERICA~~

~~NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~NOTE 5 – NOTE PAYABLE~~$385,302.

On January ~~20, 2017,~~2, 2018, the Company financed the premium for directors’ and officers’ insurance. The Company borrowed ~~$22,216~~$26,921 at 6.00% interest, and the note will be repaid in 10 equal installments of ~~$2,883.~~$3,079. As of June 30, ~~2017,~~2018, the balance of the note payable was ~~$13,462.~~$12,139.

~~NOTE 6 – DERIVATIVE FINANCIAL INSTRUMENTS~~

On January 25, 2018, the Company financed the premium for liability insurance. The Company ~~entered into a variable rate senior secured convertible debenture, wherein~~borrowed $22,230 at 6.00% interest, and the ~~Company agreed to register the underlying share, warrants and greenshoe. The fair value~~note will be repaid in 10 equal installments of the beneficial conversion feature of the warrants and greenshoe was estimated using the Black Scholes pricing model and totaled $952,254 upon issuance and was recorded as a derivative liability. As of March 9, 2015 and March 31, 2015, the fair value of the unregistered conversion feature of the Note Payable based on the following assumptions (Life 0, risk-free interest rate 0, volatility of 0, and stock price of $.15 and conversion price of $.25) was $0, resulting in the recording of a gain totaling $311,244.$2,287. As of June 30, ~~2017,~~2018, the ~~fair value~~balance of the ~~warrants based on the following assumptions (Life .19 years, risk free interest rate 1.03%, volatility of 204.47%, stock price of $.10 and exercise price of $.50)~~note payable was ~~$8,429, and a gain totaling $45,059 was recorded for the six months ended June 30, 2017.~~$13,476.

NOTE ~~7 – FAIR VALUE OF FINANCIAL INSTRUMENTS~~

~~The Fair Value Measurement and Disclosure Topic of FASB and ASC:~~

Defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, and establishes a framework for measuring fair value;

~~Establishes a three-level hierarchy for fair value measurement based upon the transparency of inputs to the valuation as of the measurement date;~~

~~Expands disclosures about financial instruments measured at fair value.~~

~~Financial assets and financial liabilities record on the Balance sheet at fair value are categorized based on the reliability of inputs to the valuation techniques as follows:~~

~~Level 1: Financial assets and financial liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company can access.~~

~~Level 2: Financial assets and financial liabilities whose values are based on the following:~~

Quoted prices for similar assets or liabilities in active markets; Quoted prices for identical or similar assets or liabilities in non-active markets or Valuation models whose inputs are observable, directly or indirectly, for substantially the full term of the assets or liability

Level 3: Financial assets and financial liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs may reflect our estimates of the assumptions that market participants would use in valuing the financial assets and financial liabilities.

~~FUTURE HEALTHCARE OF AMERICA~~

~~NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~NOTE 7 – FAIR VALUE OF FINANCIAL INSTRUMENTS - Continued~~

~~The following tables summarize Level 1, 2 and 3 financial assets and financial (liabilities) by their classification in the Consolidated Balance Sheet:~~


~~As of June 30, 2017:~~	~~Level 1~~	~~Level 2~~	~~Level 3~~
~~Derivative liability – Conversion feature of warrants~~	-	-	~~(8,429)~~
~~As of December 31, 2016~~
~~Derivative liability – Conversion feature of warrants~~	-	-	~~(53,488)~~

~~NOTE 8~~5 - CAPITAL STOCK

Common Stock - The Company has authorized 200,000,000 shares of common stock, $0.001 par value. As of June 30, ~~2017,~~2018, 11,265,631 shares were issued and outstanding.

NOTE 96 – WARRANTS ~~AND GREENSHOE~~

~~A summary of the status of the warrants granted is presented below for the six months ended:~~

June 30, 2017

December 31, 2016

Shares

Weighted Average Exercise Price

Shares

Weighted Average Exercise Price
Outstanding at beginning of period
3,030,000
$
0.50

3,030,000
$
0.50
Granted
-

-

-

-
Exercised
-

-

-

-
Forfeited
-

-

-

-
Expired
-

-

-

-
Outstanding at end of period
3,030,000
$
0.50

3,030,000
$
0.50

On September 9, 2013, the Company closed a Subscription Agreement wherein the Company granted warrants to purchase a total of 3,030,000 shares of common stock, at $0.50 per share, exercisable for four years. On September 9, 2017 the expiration date of the warrants was extended to September 9, 2018.

A summary of the status of the warrants granted is presented below for the three months ended:


	June 30, 2018				December 31, 2017
	Shares		Weighted Average Exercise Price	Shares			Weighted Average Exercise Price
Outstanding at beginning of period	3,030,000	$	0.50	3,030,000		$	0.50
Granted	-		-	-			-
Exercised	-		-	-			-
Expired	-		-	-			-
Outstanding at end of period	3,030,000	$	0.50	3,030,000		$	0.50

FUTURE HEALTHCARE OF AMERICA

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 107 - INCOME TAXES

The Company accounts for income taxes in accordance with FASB ASC Topic 740, Accounting for Income Taxes which requires the Company to provide a net deferred tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting and any available operating loss or tax credit carryforwards.

Because of the uncertainty surrounding the realization of the loss carryforwards and significant changes in the ownership of the Company, a valuation allowance has been established equal to the tax effect of the loss carryforwards and, therefore, no deferred tax asset has been recognized for the loss carryforwards. The net deferred tax assets are approximately ~~$1,300,000~~$1,100,000 as of June 30, ~~2017,~~2018, with an offsetting valuation allowance of the same amount. ~~The changes in the valuation allowance for the six months ended June 30, 2017 was approximately $49,000.~~

~~FUTURE HEALTHCARE OF AMERICA~~

~~NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

NOTE 118 – LEASES

Operating Lease - The Company leases office space in Casper, Wyoming for $4,892 a month through June 2018. The Company further leases space in Billings, Montana for $1,525 a month through ~~June~~May 2020.

The future minimum lease payments for non-cancelable operating leases having remaining terms in excess of one year as of June 30, ~~2017~~2018 are as follows:


Twelve months ending June 30		Lease Payments		Lease Payments
2018		77,004
2019		18,300		18,300
2020		16,775		16,775
2021		-		-
Thereafter		-		-
Total Minimum Lease Payments	$	112,079	$	35,075

Lease expense charged to operations was ~~$38,327~~$38,502 and ~~$38,292~~$38,327 for the six months ended June 30, ~~2017~~2018 and ~~2016,~~2017, respectively.

NOTE 129 – INCOME/ (LOSS) PER SHARE

~~The following data shows the amounts used in computing income (loss) per share and the weighted average number of shares of common stock outstanding for the periods presented for the periods ended:~~

At June 30, ~~2017~~2018 and ~~2016,~~2017, the Company had 3,030,000 and 3,030,000, respectively, warrants to purchase common stock of the Company at $0.50 per share, and a convertible debenture payable wherein the holder could convert the note and underlying accrued interest into a minimum of ~~7,269,953~~10,100,000 and ~~5,817,076,~~4,040,000, respectively shares of common stock which were not included in the loss per share computation because their effect would be anti-dilutive.

NOTE 10 – COMMITMENTS AND CONTINGENCIES

On June 17, 2016 a complaint was filed with the Wyoming State Department of Labor against the Company, alleging discrimination on the basis of sex and disability. The complaint did not seek any specific monetary relief. The complaint was mediated by the Wyoming State Department of Labor. The Wyoming State Department of Labor issued a notice of dismissal for the complaint. On February 9, 2018, this former employee filed a lawsuit against Interim Healthcare of Wyoming, claiming wrongful termination. After reviewing the facts and circumstances, the Company believes the claims made are weak, at best, and the Company has retained counsel and intends to continue a vigorous defense.

At this time, management cannot reasonably estimate the cost to defend or the outcome of the complaints, and we do not expect it will have a material financial impact on the Company.

FUTURE HEALTHCARE OF AMERICA

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 10 – COMMITMENTS AND CONTINGENCIES - Continued

On June 30, 2016 a complaint was filed with the Federal Equal Employment Opportunity Commission (EEOC) against the Company, alleging wage discrimination on the basis of sex.

On June 1, 2018, The U.S. EEOC made a determination that Interim Healthcare of Wyoming violated the Wage discrimination laws (Title VII of the Civil Rights Act of 1964) by paying a male employee more than female employees. The EEOC has determined that back wages for these individuals plus liquidated damages total $43,593, and the Company has recorded an accrual for $17,593 of this amount, as the remainder is in dispute. The company has voluntarily entered into the Conciliation Process with the EEOC to reach a resolution of the matter.

NOTE 11 – RELATED PARTY

During the first six months of 2018, an officer of the Company advanced $23,000 to the company for operating purposes. The advance bears no interest or maturity. The balance due to the officer is $23,000, as of June 30, 2018.

NOTE 1312 - SUBSEQUENT EVENTS

Subsequent events have been evaluated through the date and time of this report. There are no material subsequent events to report.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

Safe Harbor Statement.

Statements made in this Form 10-Q which are not purely historical are forward-looking statements with respect to the goals, plan objectives, intentions, expectations, financial condition, results of operations, future performance and business of the Company, including, without limitation, (i) our ability to gain a larger share of the home healthcare industry, our ability to continue to develop services acceptable to our industry, our ability to retain our business relationships, and our ability to raise capital and the growth of the home healthcare industry, and (ii) statements preceded by, followed by or that include the words "may", "would", "could", "should", "expects", "projects", "anticipates", "believes", "estimates", "plans", "intends", "targets", "tend" or similar expressions.

Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond the Company's control) that could cause actual results to differ materially from those set forth in the forward-looking statements, including the following, in addition to those contained in the Company's reports on file with the Securities and Exchange Commission: general economic or industry conditions, nationally and/or in the communities in which the Company conducts business, changes in the interest rate environment, legislation or regulatory requirements, conditions of the securities markets, changes in the home healthcare industry, the development of services that may be superior to the services offered by the Company, competition, changes in the quality or composition of the Company's services, our ability to develop new services, our ability to raise capital, changes in accounting principles, policies or guidelines, financial or political instability, acts of war or terrorism, other economic, competitive, governmental, regulatory and technical factors affecting the Company’s operations, services and prices.

Accordingly, results actually achieved may differ materially from expected results in these statements. Forward-looking statements speak only as of the date they are made. The Company does not undertake, and specifically disclaims, any obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.

Business Highlights

Based in Casper, Wyoming, and Billings, Montana, FHA’s subsidiary, Interim Healthcare of Wyoming, Inc., a Wyoming corporation (“Interim”), is an independent franchisee of Interim HealthCare that has been serving its community for over 20 years and is providing a wide range of visiting nurse services to the elderly, wounded and sick. It is one of the 300 independent home health agencies that comprise the Interim HealthCare network. Our business consists of providing healthcare services for those in need. We record all revenue and expenses and provide all services under one umbrella. Below is a description of our Home Healthcare and Staffing operations.

Our business is driven by a number of different factors and fluctuates significantly as they change.

As the census (number of patients utilizing facilities) in the hospitals fluctuates, we are taking the necessary steps to position ourselves for the ups and downs of the census for these facilities. ~~Our home healthcare service continued to generate~~While it constituted the majority of our revenue during the ~~second quarter~~first six months of ~~2017.~~2018, our home healthcare business was down significantly from the previous year. The decrease in business has been driven by the following factors.

As the need for labor diminishes with the gas and oil wells shutting down in Wyoming, our business has seen dramatic negative impacts with the resulting decrease in population, both in number of clients as well as available personnel. Historically, as the price of gas decreases, the drilling operations stop, and the population has moved to another area to support themselves. Our operations are also heavily influenced by increases in minimum wage as well as starting wages being offered by all employers in the region. With the multiple businesses paying higher starting wages, we have seen a decrease in individuals wanting and needing to take employment in the healthcare profession, and we have been unable to continue increasing our starting wages. Additionally, we have seen an increase in direct competition in the market place for the business and clients we serve.

We have also seen the impact of turn-over in senior management with our clients. As these positions are filled by new personnel, their decisions on utilization of services impacts our businesses, and we have seen a significant decrease in the utilization of our services.

During the ~~second quarter~~six months of ~~2017,~~2018, FHA experienced a 5%27% decrease in revenue over the ~~second quarter~~first six months of ~~2016.~~2017. This was driven by decreases in both our Casper, Wyoming and Billings, Montana businesses. We do not foresee a ~~decrease~~change in this trend through the end of 2018. We continue to see increased costs to provide services and decreases in reimbursement rates, reducing margins, and making it difficult to cover overhead costs. This can be seen in our ~~Billings, Montana staffing businesses, which was partially off-set by an increase in home healthcare business in Billings, Montana and Casper, Wyoming.~~results during the first six months of 2018.

During the ~~second quarter~~six months of ~~2017,~~2018, we have seen a significant decrease in the utilization staffing services in Billings, Montana as facilities that use our services receive directives to remove and reduce the use of staffing services. We’ve also seen significant decreases within our home healthcare services. As for our operations, we anticipate the trends seen in the ~~second quarter~~first six months of ~~2017~~2018 to continue ~~into the fourth quarter of 2017.~~throughout 2018. We anticipate a continued slowing of the use of our staffing services. We also anticipate a continued slowing of the utilization of our home healthcare business in ~~Casper.~~Casper and Billings. We have seen an increase in the competition, specifically in Casper, Wyoming, which is contributing to the decrease in our revenue. As such, we ~~will continue to evaluate opportunities to expand~~are evaluating other options outside the ~~realm of services we offer.~~home healthcare industry. Promotional activities and operations are being managed as the offices experience fluctuations in the day-to-day activities and as we embark on new business opportunities.

Our home healthcare business continues to be a substantial revenue generator for our Company as our country's population ages and new methods of patient data capture become critical components for delivering high quality, affordable healthcare services in a patient's home.

Home Healthcare

Through trained health care professionals, the Company provides home care services including senior care and pediatric ~~nursing, and~~nursing; physical, occupational and speech therapy. The Company offices deliver quality home care and treat each patient with genuine compassion, kindness and respect. The Company provides health care professionals at all skill levels, including registered nurses, therapists, LPN's and certified home health aides. FHA derives ~~its~~is revenue from multiple payer sources. These include Medicare, Medicaid, Insurance, Medicaid LTW, and Private Payers. Because our offices are located in areas that do not contain a large population base (less than 200,000 residents), we continually explore opportunities to increase our revenue with our current payer sources and expand through new sources of revenue. The healthcare team is utilized across all payer sources, including staffing services. Our customer base comes from referrals from hospitals, rehab facilities, nursing homes, assisted living facilities and previous patients.

In additional to our professional team, we employ a management team at each facility to handle the day to day operations of the office. This is completed by our Administrators in each location. We also have a Director of Nursing in each location. This person is responsible for the day to day oversight of the service providers and ensuring the certified professionals obtain the necessary training to maintain their certificates as well as the training necessary to be in compliance with all regulating organizations.

Staffing

Interim offices provide nurses, nurse aides and management services to hospitals, prisons, schools, corporations and other health care facilities. Interim’s success is based on our ability to recruit the best health care professionals and the responsiveness of our local managers to fill the needs of our clients in a timely manner. Additionally, we work with our clients should they decide they would like to hire our service professionals on a full time basis. Another key to our success is the personal relationship that our management and sales team build with each of our existing and new clients. As noted previously, in order to reduce turnover of our service team by providing as many hours as possible, similar to the hours of a full-time employee, we utilize the same service team members across all payer sources.

As each of our businesses is located in smaller based population areas of the country, the competition is significantly heightened and the relationships maintained with our clients become very critical to the continued success of our operations.

As we provide diversified services and accept payments from multiple payer sources, we are not heavily dependent on a few clients in order for our business to be successful.

Results of Operations

Six Months Ended June 30, ~~2017~~2018 and ~~2016.~~2017.

During the six months ended June 30, ~~2017,~~2018, FHA recorded revenues of ~~$1,950,851,~~$1,414,738, a 6%27% decrease over revenues of ~~$2,069,557~~$1,950,851 for the same period in ~~2016.~~2017. The decrease for ~~2017 reflects~~2018 was driven by a significant decrease in ~~revenue within~~the use of our staffing services in ~~the Billings, Montana location, with an off-set from an increase in revenue in home healthcare in the~~ Billings, Montana, and our home healthcare services in Casper, Wyoming ~~locations.~~ and Billings, Montana. In Casper, Wyoming, the decrease is being driven by additional licenses for Medicare being obtained by our competition, and there is additional competition for the Medicare business anticipated before the end of 2018.

For the six months ended June 30, ~~2017,~~2018, cost of services totaled ~~$1,399,372,~~$1,038,716, a 9%26% decrease compared to ~~$1,537,047~~$1,399,372 in the comparable period of ~~2016.~~2017. This is a reflection of the costs associated with the overall reduction of revenue, ~~and the change~~off-set by an increase in ~~mix~~wage cost for delivery of ~~the revenue lost.~~services. FHA posted a gross profit of ~~$551,479~~$376,022 during the first six months of ~~2017,~~2018, versus a gross profit of ~~$532,510~~$551,479 for the first six months of ~~2016, an increase~~2017, a decrease of 4%32%.

FHA recorded total operating expenses of ~~$662,949~~$621,603 during the first six months of ~~2017,~~2018, a ~~less than 1% increase~~6% decrease as compared to operating expenses of ~~$660,423~~$662,949 in the same period of ~~2016.~~2017. General and administrative expenses totaled $229,001 in the first six months of 2018 versus $215,564 in the first six months of 2017, ~~versus $200,807 in the first six months of 2016,~~ an increase of 7%6%, ~~due to~~driven by an increase in ~~directors’~~bade debt expense and ~~officers’ insurance~~offset by a decrease in recruiting fees, legal fees and ~~recruiting~~professional fees. Consulting fees decreased minimally from ~~$79,860~~$67,983 to ~~$67,983~~$66,105 when comparing the first six months of ~~2016~~2017 versus ~~2017. The decrease was driven by a reduction in the use of a consultant in 2017.~~2018. Salaries, wages and related expenses ~~increased slightly~~decreased 10% to ~~$347,736~~$311,237 in the first six months of 2018 from $347,736 in 2017 ~~from $347,095~~driven by a decrease in ~~2016.~~personnel with the decrease in business. Selling expenses in the first six months of ~~2017~~2018 were ~~$31,666~~$15,260 versus ~~$32,661~~$31,666 in the comparable period of ~~2016.~~2017, driven by a decrease in advertising.

For to the first six months of 2018, other expense included $51,481 of interest expense on the note payable. By way of comparison, for the first six months of 2017, other income and expense included $45,059 for recognition of a gain on the derivative liability and $50,993 of interest expense on the notes payable. ~~For to the first six months of 2016, other expense included $145,979 for recognition of a gain on the derivative liability and $50,500 of interest expense on the note payable.~~

FHA’s net loss available to common shareholders was ~~$117,196~~$296,943 for the first six months of ~~2017.~~2018. This represents a ~~264%~~153% increase from our net loss of ~~$32,232~~$117,196 in the first six months of ~~2016.~~2017.

Three Months Ended June 30, ~~2017~~2018 and ~~2016.~~2017.

During the three months ended June 30, ~~2017,~~2018, FHA recorded revenues of ~~$955,423,~~$642,480, a 5%33% decrease over revenues of ~~$1,010,981~~$955,423 for the same period in ~~2016.~~2017. The decrease for ~~2017 reflects~~2018 was driven by a significant decrease in ~~revenue within~~the use of our staffing services in ~~the Billings, Montana location, with an off-set from an increase in revenue in home healthcare in the~~ Billings, Montana, and our home healthcare services in Casper, Wyoming ~~locations.~~and Billings, Montana. In Casper, Wyoming, the decrease is being driven by additional licenses for Medicare being obtained by our competition, and there is additional competition for the Medicare business anticipated before the end of 2018.

For the quarter ended June 30, ~~2017,~~2018, cost of services totaled ~~$697,887,~~$497,257, a 9%29% decrease as compared to ~~$769,757~~$697,887 in the comparable period of ~~2016.~~2017. This is a reflection of ~~shift in~~ the ~~revenue mix, increased utilization, and~~costs associated with the overall reduction of revenue, ~~resulting~~off-set by an increase in wage cost for delivery of services. FHA ~~posting~~posted gross profit of ~~$257,536~~$145,223 during the second quarter ~~2017,~~2018, versus a gross profit of ~~$241,224~~$257,536 for the second quarter of ~~2016, an increase~~2017, a decrease of 7%44%.

FHA recorded total operating expenses of ~~$302,796~~$298,581 during the second quarter of ~~2017,~~2018, a 6%1% decrease as compared to operating expenses of ~~$322,989~~$302,796 in the same period of ~~2016.~~2017. General and administrative expenses totaled $119,085 in the second quarter 2017 versus $89,635 in the second quarter 2017, ~~versus $101,196~~an increase of 33% driven by an increase in ~~the second quarter 2016, a decrease of 11%, due to efforts to control spending.~~bad debt expense. Consulting fees ~~decreased~~increased to ~~$20,684~~$23,347 from ~~$29,617~~$20,684 when comparing the second quarter of ~~2017~~2018 versus ~~2016. The decrease was driven by a reduction in the use of a consultant in~~ 2017. Salaries, wages and related expenses ~~increased~~decreased to ~~$177,895~~$151,432 in the second quarter of 2018 from $177,895 in 2017, ~~from $175,812~~a decrease of 15%, driven by a decrease in ~~2016, an increase of 1%.~~personnel. Selling expenses in the second quarter of ~~2017~~2018 were ~~$14,582~~$4,717 versus ~~$16,364~~$14,582 in the comparable quarter of ~~2016.~~2017, driven by a decrease in advertising.

FHA’s net loss available to common shareholders was ~~$46,259~~$179,140 for the second quarter of ~~2017.~~2018. This represents a ~~6% decrease~~287% increase from our net loss of ~~$49,176~~$46,259 in the second quarter of ~~2016.~~2017.

Liquidity and Capital Resources.

Cash on hand was ~~$95,480~~$54,538 at June 30, ~~2017,~~2018, a decrease of ~~$110,872~~$103,534 from the ~~$206,352~~$158,072 on hand at December 31, ~~2016.~~2017. Cash used in operations for the six months ended June 30, ~~2017,~~2018, was ~~$124,334,~~$102,997, versus cash ~~provided by~~used in operation of ~~$26,732~~$102,118 for the six months ended June 30, ~~2016.~~2017. The ~~decrease~~increase is ~~driven by operating results coupled with~~ a ~~lack~~result of ~~collection~~the increase of accounts ~~receivables.~~receivables and our results of operations in our Casper and Billings locations.

The Company has insufficient cash to finance operations and continues to incur losses and accumulated deficit and has a short-term note payable in default in excess of anticipated cash. These factors raise substantial doubt about the ability of the Company to continue as a going concern. There is no assurance that the Company will be successful in achieving profitable operations or finding additional equity or debt financing. During the second quarter of 2018, an officer of the Company advanced $23,000 to the Company for operating purposes.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not required for smaller reporting companies.

Item 4. Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures

Our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")), which we refer to as disclosure controls, are controls and procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this report, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. There are inherent limitations to the effectiveness of any control system. A control system, no matter how well conceived and operated, can provide only reasonable assurance that its objectives are met. No evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

As of June 30, ~~2017,~~2018, an evaluation was carried out under the supervision and with the participation of our management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that, as of such date, the design and operation of these disclosure controls were effective to accomplish their objectives at the reasonable assurance level.

(b) Changes in Internal Control over Financial Reporting

No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act), occurred during the fiscal quarter ended June 30, ~~2017~~2018 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

On June 17, 2016 and June 30, 2016 two complaints were filed, one with the Federal Equal Employment Opportunity Commission ~~(EEOC)~~(“EEOC”) and one with the Wyoming State Department of Labor against the Company, alleging discrimination on the basis of sex and disability. The complaints do not seek any specific monetary relief. The complaints are being mediated by the Wyoming State Department of ~~Labor. The Company~~Labor, and the ~~Plaintiff are working a settlement with the assistance of the~~U.S. Equal Employment Opportunity Commission. The Wyoming State Department of ~~Labor.~~Labor issued a notice of dismissal for one of the complaints. After reviewing the facts and circumstances, the Company believes the claims made are weak, at best, and the Company has retained counsel and intends to continue a vigorous defense. On March 6, 2018, a complaint

was filed with the Wyoming Court of Natrona County, alleging violation of the Wyoming Fair Employment Practices Act of 1965 for discrimination based upon sex, disability and retaliation. The complaint does not seek any specific monetary relief. At this time, management cannot reasonably estimate the cost to defend or the outcome of the ~~complaints,~~complaints.

On June 1, 2018, The U.S. EEOC made a determination that Interim Healthcare of Wyoming violated the Wage discrimination laws (Title VII of the Civil Rights Act of 1964) by paying a male employee more than female employees. The EEOC has determined that back wages for these individuals plus liquidated damages total $43,593, and ~~we do not expect it will have~~the Company has recorded an accrual for $17,593 of this amount as the remainder is in dispute. The company has voluntarily entered into the Conciliation Process with the EEOC to reach a ~~material financial impact on~~resolution of the ~~Company.~~matter.

Item 1A. Risk Factors.

Not required for smaller reporting companies.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None; not applicable.

Item 3. Defaults Upon Senior Securities.

None; not applicable.

Item 4. Mine Safety Disclosures.

None; not applicable.

Item 5. Other Information.

(a)

~~None; not applicable.~~On May 18, 2018, the Company and Natur Holding B.V., a Netherlands-based holding company (“Natur”), executed a non-binding letter of intent for the Company to acquire all of Natur’s outstanding capital stock pursuant to a reverse triangular merger or share exchange on mutually agreeable terms. Natur is Europe's first hi-tech health food and beverage company with a mission to revolutionize natural juice and snack consumption, allowing consumers to afford a better quality of life through natural and functional nutrition. See the Company’s Current Report on Form 8-K dated May 18, 2018 and filed with the Securities and Exchange Commission on May 21, 2018.

(b) During the quarterly period ended June 30, ~~2017,~~2018, there were no changes to the procedures by which shareholders may recommend nominees to the Company’s board of directors.

Item 6. Exhibits.

Exhibit No.

Description

31.1

302 Certification of Christopher J. Spencer

31.2

302 Certification of John Busshaus

906 Certification.

1617

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

FUTURE HEALTHCARE OF AMERICA


Date:	8/~~11/17~~10/18	By:	/s/ Christopher J. Spencer
			Christopher J. Spencer
			Chief Executive Officer and President and Director


Date:	8/~~11/17~~10/18	/s/ John Busshaus
		John Busshaus
		Chief Financial Officer

1718


WYOMING	45-5547692
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)


	Page


Unaudited Condensed Consolidated Balance Sheets	3

Unaudited Condensed Consolidated Statements of Operations	4

Unaudited Condensed Consolidated Statements of Cash Flows	5

Notes to Unaudited Condensed Consolidated Financial Statements	6


	June 30, 2017	December 31, 2016	June 30, 2018 (Unaudited)	December 31, 2017
CURRENT ASSETS:
Cash	$ 95,480	$ 206,352	$ 54,538	$ 158,072
Accounts receivable	561,219	473,388
Accounts receivable, net			506,600	400,584
Prepaid expenses	57,949	60,799	39,084	31,390
Total current assets	714,648	740,539	600,222	590,046

Deferred tax asset, net	-	-	-	-
Total assets	$ 714,648	$ 740,539	$ 600,222	$ 590,046

CURRENT LIABILITIES:
Accounts payable	99,831	70,658	251,172	103,787
Advance related party			23,000	-
Accrued expenses	447,916	350,715	641,512	548,052
Derivative liability	8,429	53,488	-	43,726
Deferred revenue	-	3,470	30,492	12,832
Note Payable	13,462	-
CONVERTIBLE SECURED DEBENTURE PAYABLE, net of discount of $0 and $0, respectively	1,010,000	1,010,000
Notes payable			25,614	-
Convertible note payable			1,010,000	1,010,000
Total current liabilities	1,579,638	1,488,331	1,981,790	1,718,397



Total liabilities	1,579,638	1,488,331	1,981,790	1,718,397

STOCKHOLDERS' (DEFICIT)
COMMITMENTS & CONTINGENCIES			-	-

STOCKHOLDERS' DEFICIT
Common stock	11,266	11,266	11,266	11,266
Additional paid-in capital	1,313,160	1,313,160	2,210,420	1,313,160
Accumulated (deficit)	(2,189,416)	(2,072,218)
Total stockholders' (deficit)	(864,990)	(747,792)
Accumulated deficit			(3,603,254)	(2,452,777)
Total stockholders' deficit			(1,381,568)	(1,128,351)
Total liabilities and stockholders' deficit	$ 714,648	$ 740,539	$ 600,222	$ 590,046


Future Healthcare of America and Subsidiaries Balance Sheet (Parenthetical)
Future Healthcare of America Balance Sheet (Parenthetical)			Future Healthcare of America Balance Sheet (Parenthetical)
Statement of Financial Position	June 30, 2017	December 31, 2016		June 30, 2018	December 31, 2017
Allowance for doubtful accounts	20,200	20,200		45,200	20,200
Common stock authorized	200,000,000	200,000,000		200,000,000	200,000,000
Common stock par value	0.001	0.001		0.001	0.001
Common stock outstanding	11,265,631	11,265,631		11,265,631	11,265,631


	Life		June 31, 2017		December 31, 2016

Furniture, fixtures and equipment	2-10 yrs	$	36,384	$	36,384
			36,384		36,384
Less: Accumulated depreciation			(36,384)		(36,384)
Property & equipment, net		$	-	$	-


		Life		June 30, 2018		December 31, 2017

Furniture, fixtures, and equipment		2-10 yrs	$	36,384	$	36,384
				36,384		36,384
	Less: Accumulated depreciation			(36,384)		(36,384)
	Property & equipment, net		$	-	$	-


		For the Three Months				For the Six Months
		June 30				June 30
		2017		2016		2017		2016

Income (loss) from continuing operations available to common stockholders (numerator)	$	(46,259)	$	(49,176)	$	(117,196)	$	(32,232)
Income (loss) available to common stockholders (numerator)		(46,259)		(49,176)		(117,196)		(32,232)
Weighted average number of common shares outstanding during the period used in loss per share (denominator)		11,265,631		11,265,631		11,265,631		11,265,631

Large accelerated filer [ ]

Accelerated filer [ ]

Non-accelerated filer [ ]

~~(Do not check if a smaller reporting company)~~

Smaller reporting company [X]

Emerging Growth company [X]